Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-07

Clinical Trial Update: Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema [Phase 4]

View source ↗

Summary

Phase 4 trial update on combination therapy for diabetic macular edema using intravitreal ranibizumab with focal/grid laser and panretinal photocoagulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Shinshu University | Conditions: Diabetic Macula Edema | Phase 4 | Status: COMPLETED